シミズ ユウコ
Shimizu Yuuko
清水 優子 所属 医学部 医学科(東京女子医科大学病院) 職種 教授 |
|
論文種別 | 原著 |
言語種別 | |
査読の有無 | 査読あり |
表題 | [The MG-QOL15 Japanese version: validation and associations with clinical factors]. |
掲載誌名 | 正式名:Rinsho shinkeigaku = Clinical neurology 略 称:Rinsho Shinkeigaku ISSNコード:18820654/0009918X |
掲載区分 | 国内 |
巻・号・頁 | 52(11),1043-6頁 |
著者・共著者 | Masuda Masayuki, Utsugisawa Kimiaki, Suzuki Shigeaki, Nagane Yuriko, Ito Suguru, Kabasawa Chiaki, Suzuki Yasushi, Shimizu Yuko, Utsumi Hiroya, Fujihara Kazuo, Uchiyama Shinichiro, Suzuki Norihiro |
発行年月 | 2012/11 |
概要 | We produced a Japanese translation of the 15-item myasthenia gravis (MG)-specific quality of life (QOL) scale (MG-QOL15), assessed its reliability and validity, and examined clinical factors affecting the self-perceived QOL in MG. Consecutive 327 patients with MG seen at six neurological centers were evaluated. All patients completed an MG-QOL15 Japanese version (MG-QOL15-J), the Beck Depression Inventory-Second Edition (BDI-II), and a generic health-related QOL questionnaire, the SF-36. Disease severity was determined according to the MG Foundation of America (MGFA) quantitative MG score and the MG composite. The MG-QOL15-J exhibited adequate internal reliability, test-retest repeatability, and concurrent validity with SF-36, disease severity, and known-patient groups categorized by MGFA postintervention status. Multivariate analysis revealed severity, dose of oral corticosteroids, and BDI-II as independent factors negatively affecting QOL. The MG-QOL15-J is anticipated to be a valuable clinical measure of QOL in Japanese patients with MG. |
DOI | 10.5692/clinicalneurol.52.1043 |
PMID | 23196510 |